SFRP1, Recombinant, Human (Secreted Frizzled Related Protein 1, SARP2, FrzA)
Catalog No : USB-S1012-86R
682.78€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | SFRP1, Recombinant, Human (Secreted Frizzled Related Protein 1, SARP2, FrzA) | ||
|---|---|---|---|
| Catalog No | USB-S1012-86R | ||
| Supplier’s Catalog No | S1012-86R | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, Mouse myeloma cell line, NS0. | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | |||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | ≥ 95%, as determined by SDS-PAGE and visualized by silver stain. Endotoxin:≤ 1 EU/ug.of the cytokine as determined by the LAL method. | ||
| Form | Supplied as a powder lyophilized from a solution containing PBS, pH 7.0, 50ug BSA/ug cytokine. Reconstitute with sterile PBS containing at least 0.1% HSA or BSA to prepare a stock solution of no less than 200ug/ml. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | ≥ 95%, as determined by SDS-PAGE and visualized by silver stain. Endotoxin:≤ 1 EU/ug.of the cytokine as determined by the LAL method. | ||
| Description | Secreted Frizzled Related Proteins (sFRPs) are a family of secreted, soluble vertebrate glycoproteins which contain homology to the Wnt-binding domain of the Frizzled (Fz) family of transmembrane receptors. sFRPs are ~30-35kD in size and are comprised of 3 domains: a signal sequence; an N-terminal Fz cysteine-rich domain (CRD) with 10 conserved cysteines; and a C-terminal heparin-binding region with weak homology to Netrin. The Fz CRD mediates Wnt-binding and is present in all Fz and sFRP family members (1). sFRP-1, also known as secreted apoptosis-related protein 2 (SARP-2), FRP and FrzA, is expressed in the embryonic kidney, eye, brain, teeth, salivary gland and small intestine, most often at sites of epithelial-mesenchyme interaction (5). Expression in the adult animal is strong in the eye, kidney, and heart and also prevalent in the brain and lung (2,5). sFRP-1 was first characterized as a protein that enhances the sensitivity of cells to apoptotic stimuli (3) and as an antagonist of Wnt signaling in Xenopus embryos (4). It is also characterized as a tumor suppressor in breast (6) and cervical carcinomas (7). In contrast, sFRP-1 is expressed by the majority of malignant gliomas (8) and contributes to the development of uterine leiomyomas (9), suggesting that the role of sFRP-1 is dependent on cell context. sFRP-1 has diverse activities, from inducing angiogenesis (10) in a variety of in vivo models to helping regulate Wnt-4 signaling (with sFRP-2) in renal organogenesis (11). Mouse and human sFRP-1 proteins share 94% amino acid identity (1). Source: A DNA sequence encoding amino acid residues Met1-Lys313 of human secreted Frizzled Related Protein-1 (hsFRP-1) (Melkonyan, H.S. et al., 1997, Proc. Natl. Acad. Sci. USA 94: 13636-13641) was expressed with a C-terminal His tag in a mouse myeloma cell line, NS0. Molecular Mass: Mature recombinant human sFRP-1 is a monomeric protein. Based on N-terminal sequencing, three peptides, Ser31, Asp41 and Phe38 at their N-termini are present in this recombinant preparation in approximately equimolar amounts. As a result of glycosylation, the recombinant preparation migrates at ~35-40kD in SDS-PAGE under reducing conditions. Biological Activity: Measured by its ability to inhibit proliferation of human HeLa cervical adenicarcinoma cells. The ED50 for this effect is typically 2.5-10ug/ml. In an alternative assay, this protein also inhibits rmWnt-3A induced activation of beta-catenin reporter TOPFLASH in HEK293T cells. Storage and Stability: Lyophilized powder may be stored at -20°C. Reconstitute to nominal volume by adding sterile PBS containing at least 0.1% HSA or BSA . Aliquot and store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. | ||
© 2020 Imugex All Rights Reserved